This med’s made to treat Acute Myeloid Leukemia that won’t go away or comes back and is tied to FLT3 gene changes. Gilteritinib is a FLT3 inhibitor—it blocks something called FLT3 kinase, which is like a helper for leukemic cell growth.
The prescribed dosage is a regimen of 120 milligrams taken orally daily, with each tablet containing 40 mg of the active substance. You’ll get these as film-coated tablets—90 tablets in each pack, by the way.
Reviews
There are no reviews yet.